Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease

Proceedings of the American Thoracic Society

Volumn 3, Issue 6, 2006, Pages 475-476

  Eddahibi, Saadia ^b   Chaouat, Ari ^b   Tu, Li ^b   Chouaid, Christos ^b   Weitzenblum, Emmanuel ^b   Housset, Bruno ^b   Maitre, Bernard ^b   Adnot, Serge ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART CATHETERIZATION; HUMAN; LUNG ARTERY PRESSURE;

DNA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; INTERLEUKIN-6; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 33747855532     PISSN: 15463222     EISSN: 15463222     Source Type: Journal    
DOI: 10.1513/pats.200603-038MS     Document Type: Conference Paper

References (4)

1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364:613-620.
2. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 1999;84:329-336.
3. Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet AS, Dartevelle P, Housset B, Hamon M, Weitzenblum E, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003;108:1839-1844.
4. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995;151:1628-1631.